Viewing Study NCT01490060

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:13 AM
Ignite Modification Date: 2026-06-30 @ 8:29 AM
Study NCT ID: NCT01490060
Status: COMPLETED
Last Update Posted: 2016-04-11
First Post: 2011-12-08
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Fosaprepitant in Patients Receiving Ifosfamide-based Regimen
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sarcoma View
None Chemotherapy-induced Nausea and Vomiting View
None Effects of Chemotherapy View
None Adverse Effects of Medical Drugs View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer View
None fosaprepitant View
None Ifosfamide-based Multi-day Chemotherapy View
None Chemotherapy-induced nausea and vomiting View
None CINV View
None multi-day chemotherapy regimens View
None antiemetics View
None adverse effect View
None doxorubicin plus ifosfamide View
None AI View
None AI and vincristine View
None VAI View
None aprepitant View
None prevention View
None nausea View
None vomiting View
None emetogenic chemotherapy View